feed,title,long_url,short_url
Benzinga,Syndax Pharmaceuticals Set for Potential Breakthrough with Revumenib: Analyst Calls It 'Potentially Best-In-Class' In Competitive Landscape,https://benzinga.com/general/biotech/23/07/33188619/syndax-pharmaceuticals-set-for-potential-breakthrough-with-revumenib-analyst-calls-it-potentially,https://da.gd/7IlbBn
Benzinga,This Is What Whales Are Betting On ASML Holding,https://benzinga.com/markets/options/23/07/33190555/this-is-what-whales-are-betting-on-asml-holding,https://da.gd/W4bW
Benzinga,This Is What Whales Are Betting On Horizon Therapeutics,https://benzinga.com/markets/options/23/07/33190551/this-is-what-whales-are-betting-on-horizon-therapeutics,https://da.gd/31Q8N3
Benzinga,RenaissanceRe Upgraded To Outperform: Analyst Eyes Potential Gains From AIG Transaction,https://benzinga.com/analyst-ratings/analyst-color/23/07/33188911/renaissancere-upgraded-to-outperform-analyst-eyes-potential-gains-from-aig-transact,https://da.gd/zq4l3
